The slip
PARKINSON RECEIPTno. 5907
22 Oct 2026, 01:35 UTCdopamine neurons, braak
predictionZNF212 in dopamine neurons tracks Braak Lewy-body stage
registered1a87c01df3ec3ab1
discovery-0.01 p=0.981 n=9
replication-0.35 p=0.349 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.01, p 0.981)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT35db17f53800bc2ff33acbc1…
follows eb0a026b660e…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 5907: ZNF212 in dopamine neurons, braak
- power
- full sample -0.21 (p 0.393, n 18), 95% CI -0.62 to +0.28. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.18 (p 0.482, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.21 (p 0.398, n 18). could be the mix.
- skeptic
- leave-one-out range -0.32 to -0.12, sign flips 0; without severely affected donors -0.21 (p 0.393, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ZNF212 in dopamine neurons.
case closed: nothing better to follow up.